Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

L Zitvogel, L Galluzzi, MJ Smyth, G Kroemer - Immunity, 2013 - cell.com
Conventional chemotherapeutics and targeted antineoplastic agents have been developed
based on the simplistic notion that cancer constitutes a cell-autonomous genetic or …

Endoplasmic reticulum stress in immunity

SE Bettigole, LH Glimcher - Annual review of immunology, 2015 - annualreviews.org
Immune responses occur in the midst of a variety of cellular stresses that can severely
perturb endoplasmic reticulum (ER) function. The unfolded protein response is a three …

Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment

Z Bai, Y Zhou, Y Peng, X Ye, L Ma - … et Biophysica Acta (BBA)-Reviews on …, 2023 - Elsevier
Mitotic catastrophe is distinct from other cell death modes due to unique nuclear alterations
characterized as multi and/or micronucleation. Mitotic catastrophe is a common and virtually …

Trial Watch: Chemotherapy with immunogenic cell death inducers

E Vacchelli, F Aranda, A Eggermont, J Galon… - …, 2014 - Taylor & Francis
Accumulating evidence suggests that the clinical efficacy of selected anticancer drugs,
including conventional chemotherapeutics as well as targeted anticancer agents, originates …

Trial watch: oncolytic viruses for cancer therapy

J Pol, N Bloy, F Obrist, A Eggermont, J Galon… - …, 2014 - Taylor & Francis
Oncolytic viruses are natural or genetically modified viral species that selectively infect and
kill neoplastic cells. Such an innate or exogenously conferred specificity has generated …

Trial watch: Chemotherapy with immunogenic cell death inducers

E Vacchelli, L Galluzzi, WH Fridman, J Galon… - …, 2012 - Taylor & Francis
The long-established notion that apoptosis would be immunologically silent, and hence it
would go unnoticed by the immune system, if not tolerogenic, and hence it would actively …

Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors

LC Antón, JW Yewdell - Journal of leukocyte biology, 2014 - academic.oup.com
MHC class I molecules display oligopeptides on the cell surface to enable T cell
immunosurveillance of intracellular pathogens and tumors. Speed is of the essence in …

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy

E Vacchelli, F Aranda, A Eggermont, J Galon… - …, 2014 - Taylor & Francis
In 1997, for the first time in history, a monoclonal antibody (mAb), ie, the chimeric anti-CD20
molecule rituximab, was approved by the US Food and Drug Administration for use in …

Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma

Y Homma, K Taniguchi, T Murakami… - Annals of surgical …, 2014 - Springer
Background Little is known about the immunological effect of neoadjuvant
chemoradiotherapy (NACRT) in the tumor microenvironment of pancreatic ductal …

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ

M Semeraro, J Adam, G Stoll, E Louvet, K Chaba… - …, 2016 - Taylor & Francis
In a series of 248 tumor samples obtained from image-guided biopsies from patients
diagnosed with ductal carcinoma in situ of the breast, we attempted to identify biomarkers …